DKK308.85
6.68% today
Copenhagen, Aug 07, 05:00 pm CET
ISIN
DK0062498333
Symbol
NOVO B

Novo Nordisk Stock price

DKK308.85
-132.35 30.00% 1M
-320.05 50.89% 6M
-315.35 50.52% YTD
-519.55 62.72% 1Y
-66.15 17.64% 3Y
+105.48 51.86% 5Y
+114.60 59.00% 10Y
+275.85 835.91% 20Y
Copenhagen, Closing price Thu, Aug 07 2025
+19.35 6.68%
ISIN
DK0062498333
Symbol
NOVO B
Industry

Key metrics

Basic
Market capitalization
DKK1.4t
Enterprise Value
DKK1.4t
Net debt
DKK77.2b
Cash
DKK41.6b
Shares outstanding
4.4b
Valuation (TTM | estimate)
P/E
12.3 | 10.7
P/S
4.5 | 4.1
EV/Sales
4.7 | 4.3
EV/FCF
19.3
P/B
9.8
Dividends
DPS
DKK11.40
Yield 1Y | 5Y
3.9% | 1.6%
Growth 1Y | 5Y
21.3% | 22.3%
Payout 1Y | 3Y
50.4% | 50.5%
Increased
18 Years
Financials (TTM | estimate)
Revenue
DKK303.1b | DKK330.8b
EBITDA
DKK155.3b | DKK169.9b
EBIT
DKK135.3b | DKK153.8b
Net Income
DKK104.6b | DKK120.3b
Free Cash Flow
DKK74.4b
Growth (TTM | estimate)
Revenue
24.1% | 13.9%
EBITDA
29.4% | 19.4%
EBIT
23.6% | 10.7%
Net Income
17.2% | 19.1%
Free Cash Flow
47.8%
Margin (TTM | estimate)
Gross
84.3%
EBITDA
51.2% | 51.4%
EBIT
44.6%
Net
34.5% | 36.4%
Free Cash Flow
24.5%
Financial Health
Equity Ratio
30.8%
Return on Equity
70.4%
ROCE
53.5%
ROIC
45.7%
Debt/Equity
0.9
More
EPS
DKK23.5
FCF per Share
DKK16.8
Short interest
-
Employees
77k
Rev per Employee
DKK3.8m
Show more

Is Novo Nordisk a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,025 stocks worldwide.

Novo Nordisk Stock Analysis

Unlock Scores for Free

Analyst Opinions

31 Analysts have issued a Novo Nordisk forecast:

17x Buy
55%
12x Hold
39%
2x Sell
6%

Analyst Opinions

31 Analysts have issued a Novo Nordisk forecast:

Buy
55%
Hold
39%
Sell
6%

Financial data from Novo Nordisk

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
303,141 303,141
24% 24%
100%
- Direct Costs 47,496 47,496
27% 27%
16%
255,645 255,645
24% 24%
84%
- Selling and Administrative Expenses 69,076 69,076
10% 10%
23%
- Research and Development Expense 44,064 44,064
28% 28%
15%
155,307 155,307
29% 29%
51%
- Depreciation and Amortization 20,023 20,023
89% 89%
7%
EBIT (Operating Income) EBIT 135,284 135,284
24% 24%
45%
Net Profit 104,615 104,615
17% 17%
35%

In millions DKK.

Don't miss a Thing! We will send you all news about Novo Nordisk directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Novo Nordisk Stock News

AD HOC NEWS
2 days ago
Ein enttäuschendes zweites Quartal hat den Anlegern von Novo Nordisk DK0062498333 zur Wochenmitte nochmals kräftige Verluste eingebrockt.
AD HOC NEWS
2 days ago
Der Pharmakonzern Novo Nordisk DK0062498333 hat im zweiten Quartal wegen der zunehmenden Konkurrenz für seine Diabetes- und Abnehmmittel Ozempic und Wegovy weniger verdient als gedacht.
AD HOC NEWS
3 days ago
Die Schweizer Großbank UBS hat Novo Nordisk DK0062498333 von "Buy" auf "Neutral" abgestuft und das Kursziel von 600 auf 340 dänischen Kronen gesenkt.
More Novo Nordisk News

Company Profile

Novo Nordisk A/S is a healthcare company, which engages in the research, development, manufacture, and marketing of pharmaceutical products. It operates through the following segments: Diabetes & Obesity Care, and Biopharmaceuticals. The Diabetes & Obesity Care segment covers products for insulin; GLP-1 and related delivery systems; oral antidiabetic products; and obesity. The Biopharmaceuticals segment offers products for haemophilia; growth hormone therapy; and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsværd, Denmark.

Head office Denmark
CEO Lars Jørgensen
Employees 76,826
Founded 1931
Website www.novonordisk.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today